Pfizer, Innovent GLP-1 drugs clear China insurance hurdle

Pfizer, Innovent GLP-1 drugs clear China insurance hurdle  Reuters

Summary aggregated from Reuters's public RSS feed. The full reporting belongs to Reuters — please read it on their site.